Development of mini-SSPedi for children 4-7 years of age receiving cancer treatments.

Deborah TomlinsonShannon HyslopEliana SteinBrenda SpieglerEmily VetteseSusan KuczynskiTal SchechterL Lee DupuisLillian Sung

Published in: BMC cancer (2019)

We developed a symptom screening tool for children with cancer and pediatric HSCT recipients between 4 and 7 years of age that is understandable and easy to complete. Future work will evaluate the psychometric properties of mini-SSPedi and develop an electronic version of the instrument.

Keyphrases

psychometric properties
papillary thyroid
young adults
squamous cell
childhood cancer
lymph node metastasis
current status
patient reported outcomes
kidney transplantation
hematopoietic stem cell